NBIX logo

Neurocrine Biosciences (NBIX) Long Term Debt

Annual Long Term Debt

$455.10 M
+$196.80 M+76.19%

December 1, 2024


Summary


Performance

NBIX Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNBIXbalance sheetmetrics:

Quarterly Long Term Debt

$455.10 M
+$203.70 M+81.03%

December 1, 2024


Summary


Performance

NBIX Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNBIXbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

NBIX Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+76.2%+80.0%
3 y3 years+3.3%+80.0%
5 y5 years+424.9%+80.0%

NBIX Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+386.7%-5.2%+429.8%
5 y5-yearat high+424.9%-8.9%+448.3%
alltimeall timeat high>+9999.0%-8.9%>+9999.0%

Neurocrine Biosciences Long Term Debt History

DateAnnualQuarterly
Dec 2024
$455.10 M(+76.2%)
$455.10 M(+81.0%)
Sep 2024
-
$251.40 M(-1.9%)
Jun 2024
-
$256.20 M(+1.3%)
Mar 2024
-
$252.90 M(-2.1%)
Dec 2023
$258.30 M(+176.3%)
$258.30 M(+200.7%)
Sep 2023
-
$85.90 M(-3.6%)
Jun 2023
-
$89.10 M(-65.7%)
Mar 2023
-
$259.90 M(+178.0%)
Dec 2022
$93.50 M(-78.8%)
$93.50 M(-3.2%)
Sep 2022
-
$96.60 M(-64.0%)
Jun 2022
-
$268.60 M(-44.1%)
Mar 2022
-
$480.20 M(+9.0%)
Dec 2021
$440.40 M(+6.8%)
$440.40 M(+0.8%)
Sep 2021
-
$437.10 M(+0.4%)
Jun 2021
-
$435.30 M(+1.4%)
Mar 2021
-
$429.50 M(+4.2%)
Dec 2020
$412.30 M(+375.5%)
$412.30 M(+396.7%)
Sep 2020
-
$83.00 M(-1.5%)
Jun 2020
-
$84.30 M(-83.1%)
Mar 2020
-
$499.70 M(+476.4%)
Dec 2019
$86.70 M(-77.7%)
$86.70 M(-81.9%)
Sep 2019
-
$478.07 M(+2.9%)
Jun 2019
-
$464.65 M(+0.9%)
Mar 2019
-
$460.58 M(+18.6%)
Dec 2018
$388.50 M(+5.1%)
$388.50 M(+2.5%)
Jun 2018
-
$378.88 M(+1.2%)
Mar 2018
-
$374.21 M(+1.2%)
Dec 2017
$369.62 M(+4810.6%)
$369.62 M(+1.2%)
Sep 2017
-
$365.11 M(+1.2%)
Jun 2017
-
$360.68 M(+7938.4%)
Sep 2010
-
$4.49 M(-11.9%)
Jun 2010
-
$5.09 M(-17.4%)
Mar 2010
-
$6.16 M(-26.4%)
Sep 2009
-
$8.38 M(+204.7%)
Jun 2009
-
$2.75 M(-8.8%)
Mar 2009
-
$3.02 M(-59.9%)
Dec 2008
$7.53 M
$7.53 M(-84.1%)
Sep 2007
-
$47.44 M(-1.0%)
DateAnnualQuarterly
Jun 2007
-
$47.93 M(-1.2%)
Mar 2007
-
$48.53 M(-1.3%)
Dec 2006
$49.15 M(-8.3%)
$49.15 M(-1.9%)
Sep 2006
-
$50.13 M(-2.1%)
Jun 2006
-
$51.20 M(-2.3%)
Mar 2006
-
$52.40 M(-2.2%)
Dec 2005
$53.59 M(-9.9%)
$53.59 M(-2.5%)
Sep 2005
-
$54.94 M(-2.6%)
Jun 2005
-
$56.40 M(-2.7%)
Mar 2005
-
$57.95 M(-2.5%)
Dec 2004
$59.45 M(+83.1%)
$59.45 M(-7.0%)
Sep 2004
-
$63.95 M(+16.4%)
Jun 2004
-
$54.93 M(+27.5%)
Mar 2004
-
$43.10 M(+32.7%)
Dec 2003
$32.47 M(+515.4%)
$32.47 M(+70.0%)
Sep 2003
-
$19.11 M(-0.1%)
Jun 2003
-
$19.12 M(+256.6%)
Mar 2003
-
$5.36 M(+1.6%)
Dec 2002
$5.28 M(+46.6%)
$5.28 M(+18.0%)
Sep 2002
-
$4.47 M(+23.1%)
Jun 2002
-
$3.63 M(+12.6%)
Mar 2002
-
$3.23 M(-10.3%)
Dec 2001
$3.60 M(+57.7%)
$3.60 M(+76.3%)
Sep 2001
-
$2.04 M(-15.7%)
Jun 2001
-
$2.42 M(+22.6%)
Mar 2001
-
$1.98 M(-13.4%)
Dec 2000
$2.28 M(+8.7%)
$2.28 M(+19.5%)
Sep 2000
-
$1.91 M(+17.4%)
Jun 2000
-
$1.63 M(-13.6%)
Mar 2000
-
$1.88 M(-10.3%)
Dec 1999
$2.10 M(-4.5%)
$2.10 M(-4.5%)
Sep 1999
-
$2.20 M(-4.3%)
Jun 1999
-
$2.30 M(+9.5%)
Mar 1999
-
$2.10 M(-4.5%)
Dec 1998
$2.20 M(+214.3%)
$2.20 M(+214.3%)
Dec 1997
$700.00 K(-12.5%)
$700.00 K(-12.5%)
Dec 1996
$800.00 K
$800.00 K(-42.9%)
Mar 1996
-
$1.40 M

FAQ

  • What is Neurocrine Biosciences annual long term debt?
  • What is the all time high annual long term debt for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual long term debt year-on-year change?
  • What is Neurocrine Biosciences quarterly long term debt?
  • What is the all time high quarterly long term debt for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly long term debt year-on-year change?

What is Neurocrine Biosciences annual long term debt?

The current annual long term debt of NBIX is $455.10 M

What is the all time high annual long term debt for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual long term debt is $455.10 M

What is Neurocrine Biosciences annual long term debt year-on-year change?

Over the past year, NBIX annual long term debt has changed by +$196.80 M (+76.19%)

What is Neurocrine Biosciences quarterly long term debt?

The current quarterly long term debt of NBIX is $455.10 M

What is the all time high quarterly long term debt for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly long term debt is $499.70 M

What is Neurocrine Biosciences quarterly long term debt year-on-year change?

Over the past year, NBIX quarterly long term debt has changed by +$202.20 M (+79.95%)